Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FNTA | P49354 | 11/20 | 0.42 |
| ▸ | FNTB | P49356 | 11/20 | 0.42 |
| ▸ | CYP11B1 | P15538 | 6/20 | 0.37 |
| ▸ | CYP11B2 | P19099 | 6/20 | 0.37 |
| ▸ | PGGT1B | P53609 | 3/20 | 0.36 |
| ▸ | FABP4 | P15090 | 1/20 | 0.35 |
| ▸ | AMPD2 | Q01433 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7971118 | 0.93 | CYP11B1 (0.42) | FNTAFNTBCYP11B1CYP11B2PGGT1B | |
| SCHEMBL7971638 | 0.83 | FNTA (0.47) | FNTAFNTBCYP11B1CYP11B2PGGT1B | |
| SCHEMBL7971733 | 0.77 | KMT2A (0.41) | FNTAFNTBCYP11B1CYP11B2PGGT1B | |
| SCHEMBL7971101 | 0.75 | FNTA (0.48) | FNTAFNTBCYP11B1CYP11B2PGGT1B | |
| SCHEMBL7968423 | 0.74 | FNTA (0.49) | FNTAFNTBCYP11B1CYP11B2PGGT1B | |
| SCHEMBL7968966 | 0.71 | FNTA (0.44) | FNTAFNTBCYP11B1CYP11B2PGGT1B | |
| SCHEMBL9484794 | 0.69 | MYC (0.37) | FABP4 | |
| SCHEMBL7972164 | 0.69 | ITGA4 (0.40) | FNTAFNTBCYP11B1CYP11B2 | |
| SCHEMBL7967527 | 0.69 | FNTA (0.44) | FNTAFNTBCYP11B1CYP11B2PGGT1B | |
| SCHEMBL7971545 | 0.68 | FNTA (0.47) | FNTAFNTBCYP11B1CYP11B2PGGT1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2001009127-A1 | BENZOXAZINE DERIVATIVES AND THEIR THERAPEUTIC USE | AVENTIS PHARMA S.A. (FR) | 2001-02-08 | — | — | WO | disclosed |